Oxaliplatin Amarox (Oxaliplatin)

Oxaliplatin is a platinum‑based chemotherapeutic agent used in the treatment of cancers that involve the gastrointestinal tract.

• Colorectal cancer: Improves survival by inhibiting tumor cell proliferation.
• Gastric cancer: Used in combination regimens to enhance tumor response.
• Pancreatic cancer: Contributes to disease control when added to multi‑drug protocols.
• Ovarian cancer: Provides additional cytotoxic effect in refractory cases.
• Esophageal cancer: Used as part of neoadjuvant chemoradiation schedules.
• Metastatic disease: Helps reduce tumor burden in various metastatic solid tumours.

• Oxaliplatin forms reactive platinum‑DNA adducts that disrupt DNA replication and transcription, leading to apoptosis of rapidly dividing cancer cells. The drug preferentially binds to guanine residues, causing intra‑ and inter‑strand cross‑links that impede tumor cell proliferation and trigger programmed cell‑death pathways.

Oxaliplatin may elicit a range of adverse reactions, from mild to severe, depending on individual tolerance and treatment context.

Common Side Effects

• Nausea and vomiting: Frequent mild to moderate episodes.
• Peripheral neuropathy: Tingling or numbness, often dose‑dependent.
• Diarrhea: Loose stools that may require supportive care.
• Fatigue: Generalized tiredness affecting daily activities.
• Thrombocytopenia: Reduced platelet count, increasing bleeding risk.
• Elevated liver enzymes: Mild transaminase rise detectable in labs.

Serious or Rare Side Effects

• Severe hypersensitivity reactions: Anaphylaxis or bronchospasm.
• Acute neurotoxicity: Sudden onset of muscle weakness or respiratory difficulty.
• Persistent peripheral neuropathy: Long‑lasting sensory deficits.
• Hemolytic anemia: Destruction of red blood cells.
• Renal impairment: Decline in kidney function requiring monitoring.

When using Oxaliplatin, clinicians should assess patient history and monitor for specific safety concerns.

• Renal function: Evaluate baseline creatinine and adjust if impaired.
• Neuropathy risk: Monitor for sensory changes and modify dosing if needed.
• Hematologic status: Check complete blood counts before each cycle.
• Pregnancy and lactation: Contraindicated; avoid use in pregnant or nursing women.
• Drug hypersensitivity: Review prior reactions to platinum agents.
• Store at ambient temperature: Keep in original packaging, protect from light and moisture.

Oxaliplatin may interact with other medicines, altering efficacy or safety. Clinicians should review concomitant therapies.

Major Interactions (Avoid)

• Aminoglycoside antibiotics: Increased risk of nephrotoxicity.
• High‑dose vitamin C: May reduce platinum‑DNA binding effectiveness.

Moderate Interactions (Monitor Closely)

• Anticoagulants: Enhanced bleeding tendency.\n- Antiemetic agents: Potential for additive sedation.
• CYP450 inducers: May affect drug clearance indirectly.
• NSAIDs: Possible impact on platelet function.
• Radiotherapy: Combined neurotoxicity risk.